Matches in Wikidata for { <http://www.wikidata.org/entity/Q80730215> ?p ?o ?g. }
Showing items 1 to 49 of
49
with 100 items per page.
- Q80730215 description "article scientifique publié en 2008" @default.
- Q80730215 description "artículu científicu espublizáu en febreru de 2008" @default.
- Q80730215 description "im Februar 2008 veröffentlichter wissenschaftlicher Artikel" @default.
- Q80730215 description "scientific article published on 16 February 2008" @default.
- Q80730215 description "wetenschappelijk artikel" @default.
- Q80730215 description "наукова стаття, опублікована в лютому 2008" @default.
- Q80730215 name "Severe exacerbation of chronic plaque psoriasis following initially effective therapy with efalizumab: clinical characterization and therapeutic management" @default.
- Q80730215 name "Severe exacerbation of chronic plaque psoriasis following initially effective therapy with efalizumab: clinical characterization and therapeutic management" @default.
- Q80730215 type Item @default.
- Q80730215 label "Severe exacerbation of chronic plaque psoriasis following initially effective therapy with efalizumab: clinical characterization and therapeutic management" @default.
- Q80730215 label "Severe exacerbation of chronic plaque psoriasis following initially effective therapy with efalizumab: clinical characterization and therapeutic management" @default.
- Q80730215 prefLabel "Severe exacerbation of chronic plaque psoriasis following initially effective therapy with efalizumab: clinical characterization and therapeutic management" @default.
- Q80730215 prefLabel "Severe exacerbation of chronic plaque psoriasis following initially effective therapy with efalizumab: clinical characterization and therapeutic management" @default.
- Q80730215 P1433 Q80730215-014FFE73-4036-4D2E-8E9D-A81BFBE106DE @default.
- Q80730215 P1476 Q80730215-A222C3E8-CE6E-46FA-9D3B-ACC890A789BE @default.
- Q80730215 P2093 Q80730215-1BB1D138-2552-4DAC-A439-0889D6913543 @default.
- Q80730215 P2093 Q80730215-4BEB3776-CB74-487C-B558-3E42B964785B @default.
- Q80730215 P2093 Q80730215-8230BFAF-ABB0-4EB3-A633-9DC1DA917AFC @default.
- Q80730215 P2093 Q80730215-B159639F-7189-4B87-B90B-7F202546488F @default.
- Q80730215 P2093 Q80730215-E75FA639-03C3-4416-B2C4-864133A7FFCD @default.
- Q80730215 P2093 Q80730215-E9CA6E25-B0E2-4617-BD73-A4650F792684 @default.
- Q80730215 P304 Q80730215-34DE3050-A6AB-4A0C-AAC5-D15BF5D9E985 @default.
- Q80730215 P31 Q80730215-9AACA408-AFBD-4C69-9B16-C1DD0BA25EC9 @default.
- Q80730215 P356 Q80730215-FE1F5DC8-36AE-41FC-B361-42EB3C938B2C @default.
- Q80730215 P407 Q80730215-76FBE369-6701-4574-AFCB-F6B894BB7948 @default.
- Q80730215 P433 Q80730215-D93BEC90-0D2F-4F1F-A5E0-B62A7FA5ADD0 @default.
- Q80730215 P478 Q80730215-D42F3D2D-02CC-4B60-B1F5-E6CAAC355EBC @default.
- Q80730215 P577 Q80730215-6D0A4081-93BD-4275-8ED3-693F2249DC45 @default.
- Q80730215 P698 Q80730215-10B301DA-C58E-463B-915A-0AD61A78CD9B @default.
- Q80730215 P921 Q80730215-5A4B7897-B759-4456-BC27-6498BBF2A76C @default.
- Q80730215 P356 J.1365-2133.2008.08455.X @default.
- Q80730215 P698 18284393 @default.
- Q80730215 P1433 Q4970191 @default.
- Q80730215 P1476 "Severe exacerbation of chronic plaque psoriasis following initially effective therapy with efalizumab: clinical characterization and therapeutic management" @default.
- Q80730215 P2093 "A Ulmer" @default.
- Q80730215 P2093 "F Wölbing" @default.
- Q80730215 P2093 "G Fierlbeck" @default.
- Q80730215 P2093 "G Metzler" @default.
- Q80730215 P2093 "M Röcken" @default.
- Q80730215 P2093 "S Schanz" @default.
- Q80730215 P304 "867-869" @default.
- Q80730215 P31 Q13442814 @default.
- Q80730215 P356 "10.1111/J.1365-2133.2008.08455.X" @default.
- Q80730215 P407 Q1860 @default.
- Q80730215 P433 "4" @default.
- Q80730215 P478 "158" @default.
- Q80730215 P577 "2008-02-16T00:00:00Z" @default.
- Q80730215 P698 "18284393" @default.
- Q80730215 P921 Q10355321 @default.